"Supraoptic Nucleus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Hypothalamic nucleus overlying the beginning of the OPTIC TRACT.
Descriptor ID |
D013495
|
MeSH Number(s) |
A08.186.211.464.497.342.650 A08.186.211.730.317.357.342.650
|
Concept/Terms |
Supraoptic Nucleus- Supraoptic Nucleus
- Nucleus, Supraoptic
- Supraoptic Nucleus of Hypothalamus
- Hypothalamus Supraoptic Nucleus
- Nucleus Supraopticus
- Supraopticus, Nucleus
Accessory Supraoptic Group- Accessory Supraoptic Group
- Accessory Supraoptic Groups
- Group, Accessory Supraoptic
- Groups, Accessory Supraoptic
- Supraoptic Group, Accessory
- Supraoptic Groups, Accessory
|
Below are MeSH descriptors whose meaning is more general than "Supraoptic Nucleus".
Below are MeSH descriptors whose meaning is more specific than "Supraoptic Nucleus".
This graph shows the total number of publications written about "Supraoptic Nucleus" by people in this website by year, and whether "Supraoptic Nucleus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Supraoptic Nucleus" by people in Profiles.
-
Neurotransmitter/neuropeptide interactions in the regulation of neurohypophyseal hormone release. Exp Neurol. 2001 Oct; 171(2):200-9.
-
Substance P and NPY differentially potentiate ATP and adrenergic stimulated vasopressin and oxytocin release. Am J Physiol Regul Integr Comp Physiol. 2001 Jan; 280(1):R69-78.
-
Differential expression of tenascin by astrocytes associated with the supraoptic nucleus (SON) of hydrated and dehydrated adult rats. J Comp Neurol. 1996 Sep 16; 373(2):186-99.
-
Antisense vasopressin oligonucleotides: uptake, turnover, distribution, toxicity and behavioral effects. J Neuroendocrinol. 1995 Jun; 7(6):419-28.